This fact also justified why the histological subtype did not reach statistical significance in the multivariate analysis, because pembrolizumab in monotherapy was approved for both histologies.
← all excerpts
PD-L1 testing and clinical management of newly diagnosed metastatic non-small cell lung cancer in Spain: MOREL study.
1
—
—